MedPath

Comparison of effect of bupropion and venlafaxine in children with hyperactivity

Phase 2
Conditions
Attention deficit hyperactivity disorder.
Attention deficit: disorder with hyperactivity, hyperactivity disorder and syndrome with hyperactivity
F90.0, F90
Registration Number
IRCT201306189175N5
Lead Sponsor
Vice chancellor for research, Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Children with attention deficit hyperactivity disorder between 7 to 10 years old with IQ more than 70 by Rion quiz and have not any psychiatric and neurological problem at interview.
Exclusion criteria: Children with attention deficit hyperactivity disorder lower than 7 years old and more than 10 years old, IQ lower than 70 and any psychiatric and neurological problem at interview.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of response to treatment. Timepoint: before the study, after each two weeks and after completing the study. Method of measurement: Connors Parent Questionnaire.;Percentage of response to treatment. Timepoint: before the study, after each two weeks and after completing the study. Method of measurement: Clinical Global Impression Scale.;Percentage of response to treatment. Timepoint: before the study, after each two weeks and after completing the study. Method of measurement: Attention deficit hyperactivity disorder rating scale IV.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath